Literature DB >> 135260

Inhibition of erythrocyte sickling by cystamine, a thiol reagent.

W Hassan, Y Beuzard, J Rosa.   

Abstract

Incubation of sickle cells with cystamine, a thiol reagnet, resulted in the formation of an intracellular S-ethylamine derivative. The rate of the reaction was dependent upon the cystamine concentration, the temperature, and the duration of the incubation. The cystamine-treated cells demonstrated a marked inhibition of sickling under hypoxic conditions, a decrease in their mean corpuscular hemoglobin concentration, and a significant increase in their oxygen affinity. The oxygen affinity of these cells was less dependent on their mean corpuscular hemoglobin concentration than that of untreated sickle cells. The minimum gelling concentration of S-ethylamine doxyhemoglobin S was slightly increased. Cystamine did not affect the intracellular pH nor the 2,3-diphosphoglycerate level. The exact contribution of the interrelated factors in cystamine inhibition of sickling (changes in oxygen affinity, mean corpuscular hemoglobin concentration, and minimum gelling concentration) has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 135260      PMCID: PMC431012          DOI: 10.1073/pnas.73.9.3288

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Titratable sulfhydryl groups of normal and sickle cell hemoglobins at O degrees and 38 degrees.

Authors:  M MURAYAMA
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

2.  [Sickling of erythrocytes studied with polarized light & electron microscopes. II. Erythrocyte internal structure; comparison with intra-erythrocytic crystals].

Authors:  M BESSIS; G NOMARSKI; J P THIERY; J BRETON-GORIUS
Journal:  Rev Hematol       Date:  1958 Apr-Jun

3.  Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance.

Authors:  K SINGER; L SINGER
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

4.  [Beta-mercaptoethylamine content of mouse tissues after combined administration of cystamine and 5-methoxytryptamine].

Authors:  V V Mordukhovich
Journal:  Radiobiologiia       Date:  1975 Jan-Feb

5.  [Equilibrium of drepanocyte hemoglobin with oxygen].

Authors:  D W ALLEN; J WYMAN
Journal:  Rev Hematol       Date:  1954

6.  [Effect of cystamine on the performance of human operators].

Authors:  M V Vasin; N N Lebedeva
Journal:  Kosm Biol Aviakosm Med       Date:  1975 Sep-Oct

7.  The concentration dependence of the oxygen affinity of haemoglobin S.

Authors:  A May; E R Huehns
Journal:  Br J Haematol       Date:  1975-07       Impact factor: 6.998

8.  Hemoglobin J Cairo: beta 65 (E9) Lys leads to Gln, A new hemoglobin variant discovered in an Egyptian family.

Authors:  M C Garel; W Hassan; M T Coquelet; M Goossens; J Rosa; N Arous
Journal:  Biochim Biophys Acta       Date:  1976-01-20

9.  Bis-(N-maleimidomethyl) ether: an antisickling reagent.

Authors:  S J Zak; G R Geller; B Finkel; D P Tukey; M K McCormack; W Krivit
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Dimethyl adipimidate: a new antisickling agent.

Authors:  B H Lubin; V Pena; W C Mentzer; E Bymun; T B Bradley; L Packer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

View more
  4 in total

1.  Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Authors:  R C Young; R E Rachal; M Del Pilar Aguinaga; B L Nelson; B C Kim; W P Winter; O Castro
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

2.  Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation.

Authors:  C T Noguchi; D A Torchia; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery.

Authors:  Yuchao Lu; Chenxi Hou; Jingli Ren; Kui Yang; Yincheng Chang; Yuxin Pei; Hai Dong; Zhichao Pei
Journal:  Int J Nanomedicine       Date:  2019-05-14

Review 4.  Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases.

Authors:  Bindu D Paul; Solomon H Snyder
Journal:  Front Neurol       Date:  2019-12-12       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.